Bristol Myers Squibb is a pharmaceutical company that discovers, develops and markets prescription medicines. Its treatments address cancer, immune disorders, heart and blood vessel conditions, and other serious illnesses. The company serves patients and healthcare providers through hospitals, clinics and pharmacies, and it carries out research and manufacturing across several countries. Bristol Myers Squibb is based in New York City in the United States.
Bristol Myers Squibb Co. trades under the code 0R1F on the London Exchange in UK, with its price quoted in US dollars (USD). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #1220 of 3787 on the London Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendFair
63/100
Mixed trend against its averages.
See the numbers →
Above 200-day average1.8%
From 52-week high-10.7%
MomentumFair
64/100
Typical recent returns for this exchange.
See the numbers →
3-month return-0.2%
6-month return3.2%
12-month, skipping last month46.8%
Stability (higher is calmer)Strong
75/100
Calmer than most: low volatility and shallow drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)27.8%
Worst drawdown, 1 year (smaller is calmer)-17.0%
LiquidityFair
53/100
Moderate trading activity.
See the numbers →
Avg daily value traded1.03M USD
Zero-volume days1.7%
IncomeWeak
29/100
Dividend is small or irregular.
See the numbers →
Dividend yield1.0%
Years with dividends4
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 42.04 – 71.07Daily closes, split-adjusted
Signals
50-day average63.46
200-day average59.73
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)2.31
Technical summary
Daily
Neutral
6 bullish · 4 neutral · 6 bearish
Weekly
Neutral
6 bullish · 1 neutral · 5 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 10
59.34
Bullish
EMA 10
59.94
Bullish
SMA 20
60.50
Bullish
EMA 20
60.62
Bullish
SMA 50
63.46
Bearish
EMA 50
61.81
Bearish
SMA 100
61.15
Bearish
EMA 100
61.26
Bearish
SMA 200
59.73
Bullish
EMA 200
59.04
Bullish
Oscillators (daily)
RSI (14)
48.76
Neutral
MACD (12, 26)
-1.02
Bearish
Momentum (12)
-0.41
Bearish
Stochastic %K (14)
62.07
Neutral
Williams %R (14)
-37.93
Neutral
CCI (20)
20.13
Neutral
Pivot points (classic, last session)
S3
59.83
S2
60.31
S1
60.56
Pivot
61.04
R1
61.29
R2
61.77
R3
62.02
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
0.63 USD
Yield on today's price
1.04%
Frequency
Annual
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
31 Dec 2025
0.6300
2 Oct 2025
0.6200
2 Jul 2025
0.6200
3 Apr 2025
0.6200
2 Jan 2025
0.6200
3 Oct 2024
0.6000
5 Jul 2024
0.6000
4 Apr 2024
0.6000
4 Jan 2024
0.6000
5 Oct 2023
0.5700
6 Jul 2023
0.5700
6 Apr 2023
0.5700
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
Prices are end-of-day closes in USD. Educational only, not financial advice.
